Dr. Matthew Risendal , DO
Urology • Fishersville, VA
70 Medical Center Cir Ste 208
Fishersville, VA 229392273
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on March 30, 2017; this date does not establish years in practice.
-
Published CMS data list 3,438 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 — Established patient outpatient office visit: 1,040 service units.
- 81003 — Automated urinalysis test: 404 service units.
- 51798 — Ultrasound measurement of bladder capacity after voiding: 318 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 25 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,607 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 563 prescription fills, including refills.
- Finasteride — 182 prescription fills, including refills.
- Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) — 113 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 25 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 60% of clinicians listed under Urology in Virginia (2024, 218 clinicians with data). Median for this group: 2,306. Middle half: 766 to 5,298.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 1,249 in 2022 to 3,438 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2022–2024.
Practice Location & Contact Primary Location
70 Medical Center Cir Ste 208
Fishersville, VA 229392273
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 1 additional practice-address record in Kalispell, MT. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 2 distinct group names: Blue Ridge Urological Pc; Kalispell Regional Medical Center Inc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Nova Southeastern College Of Osteo Medicine
2017
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
813 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $279,010 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $208,602 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
3,446 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$126,654 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $592.07 across 26 records.
By nature of payment
- Food and Beverage: $592.07 across 26 records.
Reporting-company totals (3 largest of 11)
- Pfizer Inc.: $113.54 across 5 records.
- Endo USA, Inc.: $95.01 across 4 records.
- UROGEN PHARMA, INC.: $76.92 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
9 years (graduated 2017)
CMS Doctors and Clinicians data list 2017 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2017
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Risendal has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Risendal as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Fishersville and Virginia
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 60% of clinicians listed under Urology in Virginia (2024, 218 clinicians with data). Median for this group: 2,306. Middle half: 766 to 5,298.
Too few clinicians listed under Urology in Fishersville have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 70% of clinicians listed under Urology in Virginia (2024, 218 clinicians with data). Median for this group: $176,111. Middle half: $72,177 to $296,677.
Too few clinicians listed under Urology in Fishersville have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 70% of clinicians listed under Urology in Virginia (2024, 218 clinicians with data). Median for this group: $131,847. Middle half: $54,881 to $222,518.
Too few clinicians listed under Urology in Fishersville have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 70% of clinicians listed under Urology in Virginia (2024, 234 clinicians with data). Median for this group: 966. Middle half: 304 to 1,617.
Too few clinicians listed under Urology in Fishersville have Medicare Part D data for 2024 to compare.
Part D drug cost
Close to the middle for clinicians listed under Urology in Virginia (2024, 234 clinicians with data). Median for this group: $86,734. Middle half: $15,005 to $302,997.
Too few clinicians listed under Urology in Fishersville have Medicare Part D data for 2024 to compare.
10 active clinicians are listed under Urology with a practice address in Fishersville, VA (359 in Virginia).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 175% from 1,249 in 2022 to 3,438 in 2024.
- 2022: 1,249
- 2023: 2,897
- 2024: 3,438
-
Medicare-allowed amount
Medicare-allowed amount increased 192% from $95,550 in 2022 to $279,010 in 2024.
- 2022: $95,550
- 2023: $230,633
- 2024: $279,010
-
Paid by Medicare
Paid by Medicare increased 175% from $75,800 in 2022 to $208,602 in 2024.
- 2022: $75,800
- 2023: $167,940
- 2024: $208,602
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 378% from 336 in 2020 to 1,607 in 2024.
- 2020: 336
- 2021: 299
- 2022: 325
- 2023: 1,337
- 2024: 1,607
-
30-day fills
30-day fills increased 598% from 494 in 2020 to 3,446 in 2024.
- 2020: 494
- 2021: 471
- 2022: 569
- 2023: 2,769
- 2024: 3,446
-
Part D drug cost
Part D drug cost increased 800% from $14,071 in 2020 to $126,654 in 2024.
- 2020: $14,071
- 2021: $12,631
- 2022: $5,596
- 2023: $108,505
- 2024: $126,654
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $335.25 in 2021 to $592.07 in 2025.
- 2021: $335.25
- 2022: $500.23
- 2023: $1,618.78
- 2024: $1,262.71
- 2025: $592.07
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 26 records totaling $592.07.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
— | General | $34.75 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
ZERBAXA | General | $33.81 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $28.56 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $27.82 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
AVEED | General | $25.82 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $25.22 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
AVEED | General | $24.88 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $24.66 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $24.31 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
AVEED | General | $24.26 |
| PROGENICS PHARMACEUTICALS, INC. |
Food and Beverage
In-kind items and services
|
PYLARIFY | General | $24.19 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUPRON DEPOT | General | $24.05 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $23.52 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $23.22 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $23.22 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $22.45 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
JELMYTO | General | $22.14 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $21.24 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
AVEED | General | $20.05 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
JELMYTO | General | $20.03 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $18.92 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $17.96 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $16.42 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $16.38 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $13.98 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2021–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2022–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
1,040 | 603 | $326.00 | $123.66 |
|
81003
Automated urinalysis test
|
404 | 258 | $6.00 | $2.20 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
318 | 215 | $31.35 | $10.87 |
|
36415
Insertion of needle into vein for collection of blood sample
|
264 | 200 | $8.00 | $7.84 |
|
84153
Psa (prostate specific antigen) measurement, total
|
261 | 197 | $46.00 | $18.02 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
199 | 155 | $230.00 | $87.67 |
|
J9217
Leuprolide acetate (for depot suspension), 7.5 mg
|
174 | 25 | $510.00 | $178.38 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
155 | 133 | $599.00 | $229.69 |
|
81002
Urinalysis, manual test
|
99 | 65 | $9.00 | $3.38 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
64 | 27 | $82.00 | $34.09 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
59 | 59 | $422.00 | $161.27 |
|
52442
Insertion of implant in urethra within prostate gland using an endoscope, each additional implant
|
56 | 13 | $129.00 | $47.59 |
|
74420
Imaging of urinary tract following injection of a contrast agent
|
46 | 34 | $194.00 | $23.27 |
|
81000
Manual urinalysis test with examination using microscope, non-automated
|
41 | 39 | $10.00 | $3.94 |
|
99223
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
|
40 | 39 | $498.00 | $165.17 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
35 | 34 | $25.00 | $15.86 |
|
76872
Ultrasound scan of pelvic region through rectum
|
33 | 31 | $478.00 | $31.17 |
|
55700
Biopsy of prostate gland
|
30 | 30 | $637.00 | $115.29 |
|
99233
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
|
25 | 15 | $257.00 | $113.07 |
|
52332
Insertion of stent in ureter using an endoscope
|
23 | 20 | $1332.39 | $129.76 |
|
52356
Crushing of stone of ureter with insertion of stent using an endoscope
|
16 | 14 | $1171.13 | $407.53 |
|
64590
Insertion or replacement of peripheral, sacral, or gastric neurostimulator generator or receiver
|
15 | 15 | $560.00 | $159.57 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
14 | 14 | $599.00 | $40.82 |
|
64561
Insertion of sacral nerve neurostimulator electrode array
|
14 | 14 | $1550.00 | $706.74 |
|
52441
Insertion of implant in urethra within prostate gland using an endoscope, 1 implant
|
13 | 13 | $526.00 | $186.90 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 563 | 47,452 | $7,975.79 | 204 |
| Finasteride | Finasteride | 182 | 15,530 | $3,120.55 | 66 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 113 | 261 | $345.42 | 97 |
| Myrbetriq | Mirabegron | 68 | 3,960 | $59,730.80 | 20 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 66 | 798 | $281.41 | 54 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 54 | 4,600 | $952.17 | 23 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 47 | 346 | $559.13 | 41 |
| Solifenacin Succinate | Solifenacin Succinate | 47 | 3,125 | $1,796.56 | 16 |
| Cephalexin | Cephalexin | 46 | 1,402 | $648.62 | 33 |
| Gentamicin Sulfate | Gentamicin Sulfate | 41 | 287 | $147.58 | — |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 40 | 1,174 | $682.85 | 23 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 39 | 1,539 | $1,132.43 | 17 |
| Gemtesa | Vibegron | 37 | 2,540 | $41,683.94 | 17 |
| Sodium Chloride | 0.9 % Sodium Chloride | 36 | 252 | $334.99 | — |
| Oxybutynin Chloride | Oxybutynin Chloride | 34 | 836 | $230.29 | 27 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 29 | 193 | $142.68 | 26 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 25 | 2,250 | $354.67 | — |
| Methenamine Hippurate | Methenamine Hippurate | 23 | 930 | $1,812.18 | — |
| Amoxicillin | Amoxicillin | 22 | 134 | $47.75 | 17 |
| Potassium Citrate Er | Potassium Citrate | 20 | 1,800 | $2,657.72 | — |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 19 | 338 | $283.65 | 16 |
| Trimethoprim | Trimethoprim | 16 | 1,380 | $562.77 | — |
| Estradiol | Estradiol | 14 | 612 | $1,095.79 | — |
| Levofloxacin | Levofloxacin | 13 | 107 | $64.34 | 13 |
| Tramadol Hcl | Tramadol Hcl | 13 | 26 | $10.09 | 13 |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2025-07-15NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20250731001987
MT
7618249707
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Kalispell Regional Medical Center Inc
350 Heritage Way, Kalispell, MT 599013167
Kalispell Regional Medical Center Inc
320 Sunnyview Ln, Kalispell, MT 599013129
Phone: 4067563526
Blue Ridge Urological Pc
70 Medical Ctr Cir, Fishersville, VA 229392273
Phone: 5403325926
Kalispell Regional Medical Center Inc
310 Sunnyview Ln, Kalispell, MT 599013129
Phone: 4067516725
Secondary Practice Locations
350 Heritage Way Ste 2300
Kalispell, MT 599013167
Phone: 4068907432
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Urology (license number reported to NPPES: MT 132544)
Registered at 70 MEDICAL CENTER CIR STE 208, FISHERSVILLE, VA 229392273 (Tel: 5403325926)
Registered at PO BOX 8310, ROANOKE, VA 240140310 (Tel: 5403453556)
NPI status registered as active in NPPES database
Registered at 3200 MACCORKLE AVE SE, CAMC MEMORIAL HOSPITAL, SURGICARE CENTER, CHARLESTON, WV 253041227 (Tel: 3043885590)
Registered at 3200 MACCORKLE AVE SE, CAMC MEMORIAL HOSPITAL, SURGICARE CENTER, CHARLESTON, WV 253041227 (Tel: 3043885590)
Recorded as MATTHEW RISENDAL, D.O.
Student in an Organized Health Care Education/Training Program
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Urology Specialists in Fishersville
- Dr. William Jones, MD
- Dr. Theodore Cisu, MD
- Dr. Sam Graham, MD
- Kaitlin Berry
- Dr. Daniel Leslie, MD, PhD
- Dr. Brian Stisser, MD
Mailing Address
Po Box 8310
Roanoke, VA 240140310
Phone: 5403453556